Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 05, 2024 08:00 ET | Source: Oxurion NV

Postponement Annual Shareholders Meeting - Amendment financial calendar

Postponement Annual Shareholders Meeting - Amendment financial calendarLeuven, BELGIUM – April 5, 2024 – 02:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in...
March 28, 2024 14:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 28, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
March 27, 2024 14:00 ET | Source: Oxurion NV

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended version

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended version Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion...
March 26, 2024 14:00 ET | Source: Oxurion NV

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR...
March 25, 2024 14:10 ET | Source: Oxurion NV

OXURION announces its presence at the Paris SmallCap event on March 28, 2024.

OXURION announces its presence at the Paris SmallCapevent on March 28, 2024. Leuven, BELGIUM - March 25, 2024 - 7:00 p.m, Oxurion NV (Euronext Brussels : OXUR), a Leuven-based biopharmaceutical...
March 22, 2024 14:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 22, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
March 21, 2024 14:00 ET | Source: Oxurion NV

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas

Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR...
March 13, 2024 14:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 13, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
March 07, 2024 13:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 07, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
March 05, 2024 13:00 ET | Source: Oxurion NV

Oxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-up

Oxurion Receives EUR 300,000 in the framework of the Atlas Funding ProgramTenth tranche fully issued and paid-up Leuven, BELGIUM, 05 March – 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a...